Revolution Medicines Inc. (NASDAQ: RVMD) Is A Bargain Stock You …

In the last trading session, 1.45 million Revolution Medicines Inc. (NASDAQ:RVMD) shares changed hands as the company’s beta touched 0. With the company’s per share price at £20.28 changed hands at -£0.99 or -4.65% during last session, the market valuation stood at £2.13B. RVMD’s last price was a discount, traded about -54.68% off its 52-week high of £31.37.

The share price had its 52-week low at £14.08, which suggests the last value was 30.57% up since then. When we look at Revolution Medicines Inc.’s average trading volume, we note the 10-day average is 1.01 million shares, with the 3-month average coming to 1.29 million. Analysts gave the Revolution Medicines Inc. (RVMD) stock a consensus recommendation rating of a Buy, calculated at a mean rating of 1.80.

If we narrow down to specifics, the data shows that 0 out of 9 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended RVMD as a Hold, 7 felt it is a Buy and 0 rated the stock as Underweight. Revolution Medicines Inc.’s EPS for the current quarter is expected to be -£0.82.

Top 5 AI Stocks to Buy for 2023 The artificial intelligence (AI) revolution is already here. And it’s about to change everything we know about everything.

According to Grand View Research, the global AI boom could grow from about £137 billion in 2022 to more than £1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.

Click Here to Download the FREE Report. Sponsored Instantly RVMD was in red as seen at the end of in last trading.

With action -2.36%, the performance over the past five days has been red. The drop to weekly highs of 22.19 on Tuesday, 04/04/23 subtracted -4.65% to the stock’s daily price. The company’s shares are showing year-to-date downside of -14.86%, with the 5-day performance at -2.36% in the red.

However, in the 30-day time frame, Revolution Medicines Inc. (NASDAQ:RVMD) is -18.68% down. Looking at the short shares, we see there were 7.17 million shares sold at short interest cover period of 7.13 days. The consensus price target for the stock as assigned by Wall Street analysts is £32.63, meaning bulls need an upside of 37.85% from its current market value.

According to analyst projections, RVMD’s forecast low is £23.00 with £38.00 as the target high. To hit the forecast high, the stock’s price needs a -87.38% plunge from its current level, while the stock would need to soar -13.41% for it to hit the projected low.

Revolution Medicines Inc. (RVMD) estimates and forecasts

Data shows that the Revolution Medicines Inc. share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 3.84% over the past 6 months, a -17.86% in annual growth rate that is considerably lower than the industry average of 13.20%.

Moreover, analysts have looked to lower expectations by upgrading its fiscal year 2023 revenue estimates. The rating firms predict current quarter revenue for Revolution Medicines Inc. will fall -5.10%, while the growth in revenue is estimated to hit -7.30% for the next quarter. Year-over-year growth is forecast to reach -77.20% down from the last financial year.

Consensus estimates given by 7 financial analysts project the company’s revenue in the current quarter to hit an average of £2.5 million.

7 analysts are of the opinion that Revolution Medicines Inc.’s revenue for the quarter ending Jun 2023 will be £1.79 million. The company’s revenue for the corresponding quarters a year ago was £7.58 million and £9.12 million respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -67.00%.

The estimates for the next quarter sales put growth at -80.40%. Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -36.10%. The 2023 estimates are for Revolution Medicines Inc. earnings to decrease by -20.00%.

RVMD Dividends

Revolution Medicines Inc. is expected to release its next quarterly earnings report between May 08 and May 12.

Revolution Medicines Inc. (NASDAQ:RVMD)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 1.73% of Revolution Medicines Inc. shares while 84.54% of the shares are in the hands of institutional holders.

The share float percentage for the stock currently stands at 86.02%. There are 84.54% institutions holding the Revolution Medicines Inc. stock share, with Wellington Management Group, LLP the top institutional holder. As of Dec 30, 2022, the company held 9.81% of the shares, roughly 8.87 million RVMD shares worth £179.96 million.

Vanguard Group, Inc. (The) holds the second largest percentage of outstanding shares, with 8.36% or 7.56 million shares worth £153.36 million as of Dec 30, 2022. Among Mutual Funds, the top two as of Dec 30, 2022 were SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF and Vanguard Total Stock Market Index Fund. With 2.27 million shares estimated at £46.09 million under it, the former controlled 2.56% of total outstanding shares.

On the other hand, Vanguard Total Stock Market Index Fund held about 2.47% of the shares, roughly 2.19 million shares worth around £44.47 million.